Quality of Life Measures in Patients With Retinal Degeneration

Status Completed

Clinical Trial Summary

Inherited retinal degeneration (IRD) is a major cause of blindness and partial loss of vision cases in the UK and starts at an early age. The purpose of this observational study is to use the results of two questionnaires and a computerised test testing contrast sensitivity, to assess the impact of IRD on quality of life. This study will involve collecting data from patients with IRD, but also collecting data from normal controls.

Clinical Trial Description

IRD presents a significant burden on the NHS as well as on the individual and families. IRDs are particularly difficult in a family situation due to guilt and other complex emotions related to inheritance patterns. Poorer mental health has been reported in patients with retinitis pigmentosa, manifesting in a range of ways including stress, depression and anxiety, particularly as the disease progresses. This is most probably caused by the uncertainty of the disease process and the progressive nature of the degeneration.

Recent work has reported that quality of life significantly deteriorates with a drop in visual field diameter of 20 degrees or a drop in visual acuity lower then LogMAR 0.3 (equivalent to 6/12). Contrast sensitivity is often used in conjunction with VA to assess visual capabilities. It is a measure of the ability to see reduced contrast and has a major impact on utility of vision. Relating contrast sensitivity function to quality of life will provide valuable information about whether this aspect of vision is a critical measure for patient health. This is especially important as novel treatments are being developed for the treatment of IRDs. ;

Study Design

Related Conditions & MeSH terms

Retinal Degeneration

Clinical Trial Details

NCT number	NCT02814435
Study type	Observational
Source	University of Oxford
Contact
Status	Completed
Phase
Start date	July 2016
Completion date	October 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01432847` - Cell Collection to Study Eye Diseases
Terminated	`NCT03561922` - Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS	N/A
Active, not recruiting	`NCT03872479` - Single Ascending Dose Study in Participants With LCA10	Phase 1/Phase 2
Completed	`NCT00231010` - Molecular Genetics of Retinal Degenerations
Recruiting	`NCT03078309` - The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients	Early Phase 1
Active, not recruiting	`NCT01736293` - Natural History of Eye Diseases Related to ABCA4 Mutations
Completed	`NCT03318549` - BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases	N/A
Completed	`NCT04919473` - Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa	Phase 1/Phase 2
Completed	`NCT03321253` - Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification	N/A
Completed	`NCT01497379` - Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients	N/A
Recruiting	`NCT04620876` - Bimodal and Coaxial High Resolution Ophtalmic Imaging	N/A
Recruiting	`NCT03592017` - Performance of Long-wavelength Autofluorescence Imaging	N/A
Completed	`NCT03150654` - The Effect of Laser Treatment on Macular Pigment of Eye in Cases With Diabetes	N/A
Recruiting	`NCT04545736` - Oral Metformin for Treatment of ABCA4 Retinopathy	Phase 1/Phase 2
Completed	`NCT00403195` - Clinical and Pathophysiological Description of Ocular Ischemic Syndrome	N/A
Enrolling by invitation	`NCT06167642` - Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab
Enrolling by invitation	`NCT02144103` - Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration	Phase 1/Phase 2
Recruiting	`NCT06289452` - Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis	Early Phase 1
Recruiting	`NCT06305416` - A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema	Phase 3
Recruiting	`NCT02617966` - Rod and Cone Mediated Function in Retinal Disease